User Login

 

 

New User?
Trouble signing in?

Our scientific advisory committee is renowned cancer MDs and PHDs with decades of experience in cancer research and clinical trials. They help us select projects and researchers who are the pioneers to curing cancer. Our grant focus is not a specific type of cancer. Rather, we provide seed grants to the projects that present the best opportunities to have a breakthrough. With the data, researchers are then able to apply for additional funding from the National Institute of Health, other foundations, and industry. Our beneficiaries have reported that for every grant dollar they receive from SAA, they are able to secure $3 in new funding they might not otherwise have received.

In over three decades, Swim Across America has granted nearly $100 million dollars that have led to breakthroughs in immunotherapy, gene therapy, personalized medicine, and patient programs. It is important donors know that our grant agreement requires 100% of SAA grants be applied to approved projects and not other things such as overhead and buildings.

There are 11 named Swim Across America research labs demonstrating the commitment and partnership of the beneficiary and Swim Across America.

 

  • SAA Cancer Support Group Lead Image

    SAA - LONG ISLAND SOUND,
    SAA - NASSAU-SUFFOLK
    Swim Across America Lab
    at Memorial Sloan Kettering Cancer Center
    FOCUS: Funding immunotherapy clinical trials that have played a major role in developing four FDA approved immunotherapy medicines ipilimumab (YERVOY), nivolumab (OPDIVO), pembrolizumab (KEYTRUDA) and atezolizumab (TECENTRIQ).
    GRANT FOR 2022: $340,000
    MEMORIAL SLOAN KETTERING TESTIMONIAL

  • SAA Cancer Support Group Lead Image

    SAA - LONG ISLAND SOUND,
    SAA - NASSAU-SUFFOLK
    Swim Across America Lab
    at Weill Cornell Medicine Meyer Cancer Center
    FOCUS: Funding immunotherapy research and clinical trials.

  • SAA Cancer Support Group Lead Image

    SAA - LONG ISLAND SOUND
    Columbia University Medical Center
    FOCUS: Pediatric oncology research; grant funding for pediatric patients who have tumor relapse.
    GRANT FOR 2022: $227,000